Changzhou Qianhong Biopharma Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.057x

Changzhou Qianhong Biopharma Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Changzhou Qianhong Biopharma Co Ltd (002550) has a cash flow conversion efficiency ratio of 0.057x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥156.34 Million ≈ $22.88 Million USD) by net assets (CN¥2.76 Billion ≈ $403.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Changzhou Qianhong Biopharma Co Ltd (2007–2025)

Cash flow conversion efficiency of Changzhou Qianhong Biopharma Co Ltd from 2007 to 2025. This chart illustrates how Changzhou Qianhong Biopharma Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Changzhou Qianhong Biopharma Co Ltd stock price for real-time trading data and today's change.

Changzhou Qianhong Biopharma Co Ltd Cash Flow Conversion Ratio Explained

Changzhou Qianhong Biopharma Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Changzhou Qianhong Biopharma Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Changzhou Qianhong Biopharma Co Ltd ranked by their cash flow conversion efficiency. Also see market value of Changzhou Qianhong Biopharma Co Ltd for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Genusplus Group Ltd AU:GNP	0.302x
Dole plc F:4CB	0.064x
Zhejiang Dayuan Pumps Ind Co SHG:603757	-0.003x
Tennant Company NYSE:TNC	0.009x
Xinjiang Machinery Research Inst SHE:300159	0.010x
Bonheur OL:BONHR	0.082x
JM Financial Limited NSE:JMFINANCIL	-0.028x
Genius Sports Ltd NYSE:GENI	-0.090x

Annual Cash Flow Conversion Efficiency for Changzhou Qianhong Biopharma Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Changzhou Qianhong Biopharma Co Ltd from 2007 to 2025. Review 002550 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.77 Billion ≈ $404.78 Million	CN¥361.36 Million ≈ $52.88 Million	0.131x	-36.13%
2024-12-31	CN¥2.52 Billion ≈ $368.25 Million	CN¥514.71 Million ≈ $75.32 Million	0.205x	-5.13%
2023-12-31	CN¥2.47 Billion ≈ $362.01 Million	CN¥533.33 Million ≈ $78.04 Million	0.216x	+833.97%
2022-12-31	CN¥2.43 Billion ≈ $356.08 Million	CN¥-71.47 Million ≈ $-10.46 Million	-0.029x	-160.08%
2021-12-31	CN¥2.12 Billion ≈ $309.95 Million	CN¥103.56 Million ≈ $15.15 Million	0.049x	-68.17%
2020-12-31	CN¥2.07 Billion ≈ $302.24 Million	CN¥317.28 Million ≈ $46.43 Million	0.154x	+121.81%
2019-12-31	CN¥2.33 Billion ≈ $341.34 Million	CN¥161.55 Million ≈ $23.64 Million	0.069x	+590.82%
2018-12-31	CN¥2.54 Billion ≈ $371.42 Million	CN¥25.45 Million ≈ $3.72 Million	0.010x	-72.22%
2017-12-31	CN¥2.45 Billion ≈ $358.94 Million	CN¥88.52 Million ≈ $12.95 Million	0.036x	-60.41%
2016-12-31	CN¥2.42 Billion ≈ $354.79 Million	CN¥221.01 Million ≈ $32.34 Million	0.091x	-27.00%
2015-12-31	CN¥2.29 Billion ≈ $335.75 Million	CN¥286.50 Million ≈ $41.92 Million	0.125x	+5.67%
2014-12-31	CN¥2.13 Billion ≈ $312.08 Million	CN¥252.01 Million ≈ $36.88 Million	0.118x	+45.10%
2013-12-31	CN¥1.97 Billion ≈ $288.35 Million	CN¥160.47 Million ≈ $23.48 Million	0.081x	-23.84%
2012-12-31	CN¥1.87 Billion ≈ $273.47 Million	CN¥199.82 Million ≈ $29.24 Million	0.107x	+28.62%
2011-12-31	CN¥1.77 Billion ≈ $258.44 Million	CN¥146.82 Million ≈ $21.48 Million	0.083x	-79.94%
2010-12-31	CN¥413.78 Million ≈ $60.55 Million	CN¥171.51 Million ≈ $25.10 Million	0.415x	+1109.63%
2009-12-31	CN¥243.68 Million ≈ $35.66 Million	CN¥8.35 Million ≈ $1.22 Million	0.034x	-86.26%
2008-12-31	CN¥217.99 Million ≈ $31.90 Million	CN¥54.36 Million ≈ $7.95 Million	0.249x	+46.60%
2007-12-31	CN¥211.61 Million ≈ $30.97 Million	CN¥35.99 Million ≈ $5.27 Million	0.170x	--

About Changzhou Qianhong Biopharma Co Ltd

SHE:002550 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.18 Billion

CN¥8.06 Billion CNY

Market Cap Rank

#7965 Global

#1757 in China

Share Price

CN¥6.30

Change (1 day)

+1.61%

52-Week Range

CN¥5.74 - CN¥9.21

All Time High

CN¥12.27